Loveleen Kang
- Immunology top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research
- Surgery
- Co-authors
- Dmitry I. GabrilovichВ. М. ПисаревSimon ShermanSrinivas NagarajJonathan P. SchneckKapil GuptaLeo KinarskyDonna L. Herber
- Topics
- Acute Myeloid Leukemia Research (3 papers)Chronic Lymphocytic Leukemia Research (3 papers)Bladder and Urothelial Cancer Treatments (2 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesSwitzerland
In The Last Decade
Loveleen Kang
18 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 785
- Oncology 459
- Molecular Biology 253
- Cancer Research 112
- Surgery 90
Countries citing papers authored by Loveleen Kang
This map shows the geographic impact of Loveleen Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loveleen Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loveleen Kang more than expected).
Fields of papers citing papers by Loveleen Kang
This network shows the impact of papers produced by Loveleen Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loveleen Kang. The network helps show where Loveleen Kang may publish in the future.
Co-authorship network of co-authors of Loveleen Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Loveleen Kang. A scholar is included among the top collaborators of Loveleen Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loveleen Kang. Loveleen Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 19 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | An Atypical Angiomyomatous Hamartoma With Unexplained Hepatosplenomegaly. | 0 |
| 6 | 7 | |
| 7 | 34 | |
| 8 | 70 | |
| 9 | Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy. | 26 |
| 10 | 36 | |
| 11 | Altered recognition of antigen is a novel mechanism of CD8+ T cell tolerance in cancer | 2 |
| 12 | Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerbreakdown → | 889 |
| 13 | 5 | |
| 14 | 11 | |
| 15 | 42 | |
| 16 | 23 | |
| 17 | 9 | |
| 18 | 3 | |
| 19 | 2 |
About Loveleen Kang
Loveleen Kang is a scholar working on Genetics, Hematology and Immunology, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Immunology (785 citations), Oncology (459 citations) and Cancer Research (112 citations). Loveleen Kang has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Dmitry I. Gabrilovich, В. М. Писарев, Simon Sherman, Srinivas Nagaraj, Jonathan P. Schneck, Kapil Gupta, Leo Kinarsky, Donna L. Herber, Wade J. Sexton and Cherie H. Dunphy. Their work appears in journals such as Nature Medicine, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.